Switch to:
GuruFocus has detected 1 Warning Sign with Biomarin Pharmaceutical Inc $BMRN.
More than 500,000 people have already joined GuruFocus to track the stocks they follow and exchange investment ideas.
Biomarin Pharmaceutical Inc (NAS:BMRN)
Additional Paid-In Capital
$4,315 Mil (As of Mar. 2017)

Biomarin Pharmaceutical Inc's quarterly additional paid-in capital increased from Sep. 2016 ($4,232 Mil) to Dec. 2016 ($4,288 Mil) and increased from Dec. 2016 ($4,288 Mil) to Mar. 2017 ($4,315 Mil).

Biomarin Pharmaceutical Inc's annual additional paid-in capital increased from Dec. 2014 ($2,360 Mil) to Dec. 2015 ($3,415 Mil) and increased from Dec. 2015 ($3,415 Mil) to Dec. 2016 ($4,288 Mil).


Capital that a company raises in a financing round in excess of the capital's par value. The account represents the excess paid by an investor over the par-value price of a stock issue. Additional paid-in-capital can arise from issuing either preferred or common stock.

Additional Paid-In Capital is calculated as

Additional Paid-In Capital=(Issue Price-Par Value)*Shares Outstanding

Related Terms

Shares Outstanding

Historical Data

* All numbers are in millions except for per share data and ratio. All numbers are in their local exchange's currency.

Biomarin Pharmaceutical Inc Annual Data

AdditionalPaidInCapital 7958539001,0901,1971,5622,0592,3603,4154,288

Biomarin Pharmaceutical Inc Quarterly Data

AdditionalPaidInCapital 2,3603,3083,3383,3713,4153,4103,4584,2324,2884,315
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)

GF Chat